Trial · NCT04865289
Adverse events324
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 324
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Lenvatinib + Pembrolizumab | 21 | 73 | 34 |
| other | Anaemia | Blood and lymphatic system disorders | Paclitaxel + Carboplatin | 43 | 56 | 107 |
| other | Leukopenia | Blood and lymphatic system disorders | Lenvatinib + Pembrolizumab | 2 | 73 | 7 |
| other | Leukopenia | Blood and lymphatic system disorders | Paclitaxel + Carboplatin | 9 | 56 | 49 |
| other | Neutropenia | Blood and lymphatic system disorders | Lenvatinib + Pembrolizumab | 0 | 73 | 0 |
| other | Neutropenia | Blood and lymphatic system disorders | Paclitaxel + Carboplatin | 9 | 56 | 26 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Lenvatinib + Pembrolizumab | 5 | 73 | 8 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Paclitaxel + Carboplatin | 8 | 56 | 12 |
| other | Palpitations | Cardiac disorders | Lenvatinib + Pembrolizumab | 4 | 73 | 4 |
| other | Palpitations | Cardiac disorders | Paclitaxel + Carboplatin | 1 | 56 | 1 |
| other | Hyperthyroidism | Endocrine disorders | Lenvatinib + Pembrolizumab | 9 | 73 | 9 |
| other | Hyperthyroidism | Endocrine disorders | Paclitaxel + Carboplatin | 0 | 56 | 0 |
| other | Hypothyroidism | Endocrine disorders | Lenvatinib + Pembrolizumab | 44 | 73 | 70 |
| other | Hypothyroidism | Endocrine disorders | Paclitaxel + Carboplatin | 3 | 56 | 4 |
| other | Abdominal distension | Gastrointestinal disorders | Lenvatinib + Pembrolizumab | 6 | 73 | 8 |
| other | Abdominal distension | Gastrointestinal disorders | Paclitaxel + Carboplatin | 0 | 56 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Lenvatinib + Pembrolizumab | 12 | 73 | 16 |
| other | Abdominal pain | Gastrointestinal disorders | Paclitaxel + Carboplatin | 5 | 56 | 5 |
| other | Abdominal pain upper | Gastrointestinal disorders | Lenvatinib + Pembrolizumab | 9 | 73 | 12 |
| other | Abdominal pain upper | Gastrointestinal disorders | Paclitaxel + Carboplatin | 1 | 56 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04865289/events